Surprising Findings on Cannabis and Cognitive Outcomes in Older Adults
Recent research on cannabis cognitive outcomes older adults challenges previous adolescent-focused findings. Older adults may experience different cognitive effects from cannabis use, highlighting the need for age-specific clinical guidance. This…
Landmark Study Reveals Cannabis Ineffective for Depression and Anxiety
A landmark study on cannabis efficacy depression anxiety found no meaningful therapeutic benefit for these conditions. This challenges common assumptions about medicinal cannabis use in mental health. Clinicians should counsel patients on evidence-based…
Lancet Reveals Key Findings on Medicinal Cannabis and Mental Health
This cannabinoid safety and efficacy mental health study offers clinicians crucial evidence for prescribing medicinal cannabis in psychiatric conditions. The Lancet review synthesizes scattered data to inform safer clinical decisions. It highlights both…
Cannabis Medicine Regulatory Updates: March 17, 2026
This update covers cannabis medicine regulatory updates relevant to clinicians and patients. Key topics include controlled substances scheduling and Medicare payment policies. These cannabis medicine regulatory updates impact clinical practice and…
Cannabis Clinical Research Digest March 2026 | CEDclinic
The Cannabis Clinical Research Digest March 2026 presents 230 items curated for clinical relevance. This digest offers healthcare providers insights into cannabis research and clinical updates. It is an essential resource for clinicians supporting…
Cannabis Labor Unionization and Industry Trends in 2026
This article reviews cannabis labor unionization and enforcement disparities in 2026. It highlights cannabinoid pharmacology and terpene profiles relevant to clinicians. Cannabis labor unionization remains a key trend in the evolving industry landscape.
Using marijuana to ease anxiety or depression? Science shows the evidence isn’t there
Recent studies show cannabis for psychiatric symptoms lacks strong evidence for anxiety or depression relief. Patients often self-medicate, risking delayed effective treatments. Clinicians should guide patients toward proven therapies instead of cannabis.
DEA Temporary Schedule I Placement: March 16, 2026 Updates
This Policy Watch covers the DEA temporary schedule I placement and 27 regulatory updates as of March 16, 2026. These updates include synthetic opioids and benzodiazepine analogs relevant to cannabis clinicians. Stay informed on controlled substances…
Cannabis Use and Trauma-Focused Treatment for PTSD & Substance Use
Cannabis use trauma-focused treatment PTSD is crucial for individuals with co-occurring substance use disorders. Evidence shows cannabis does not undermine PTSD treatment effectiveness. Trauma-focused treatments remain beneficial even with cannabis use.
Does medicinal cannabis work for depression, anxiety or PTSD? Our study says there’s no evidence
Current medicinal cannabis depression anxiety PTSD evidence shows no strong support for its effectiveness. Clinicians should counsel patients accordingly. This highlights the need for more rigorous research.